Who We Are

Founded by pioneers in tolerance and regulatory T cell (Treg) biology, SonomaBio launched in 2019 with backing from top life science investors and has since built a world-class team of scientists, clinicians, and industry veterans.

Dscf4191 Aspect Ratio 388 406
Sonomabio Conferenceroom 0145 Aspect Ratio 276 264

Meet the people who lead, support, and advise us.

  • Michele Lab 1x1

    Michelle Blake

    Vice President, Translational Sciences

  • Sabrina Fox Bosetti 1x1

    Sabrina Fox-Bosetti

    Vice President, Clinical Operations

  • Mark Lab 1x1 V2

    Mark Fromhold

    Vice President, Manufacturing & Supply Chain

  • Herve Aspect Ratio 1 1

    Herve Lebrec

    Vice President, Development Sciences

  • Amanda 1x1 Aspect Ratio 1 1

    Amanda Pace

    Vice President, Analytical & Process Development

  • Sameer Hallway 1x1

    Sameer Sivaamnuaiphorn

    Vice President, Program Team Lead, 7101 Program

  • Anavelys 1x1

    Anavelys Ortiz Suarez

    Vice President, Intellectual Property and Legal Operations 

  • Yuanyuan Hallway 1x1

    Yuanyuan Xiao

    Vice President, Data Sciences

Michele Lab 1x1

Michelle Blake

Vice President, Translational Sciences
Sabrina Fox Bosetti 1x1

Sabrina Fox-Bosetti

Vice President, Clinical Operations
Mark Lab 1x1 V2

Mark Fromhold

Vice President, Manufacturing & Supply Chain
Herve Aspect Ratio 1 1

Herve Lebrec

Vice President, Development Sciences
Amanda 1x1 Aspect Ratio 1 1

Amanda Pace

Vice President, Analytical & Process Development
Sameer Hallway 1x1

Sameer Sivaamnuaiphorn

Vice President, Program Team Lead, 7101 Program
Anavelys 1x1

Anavelys Ortiz Suarez

Vice President, Intellectual Property and Legal Operations 
Yuanyuan Hallway 1x1

Yuanyuan Xiao

Vice President, Data Sciences
Sonomabio Lab 0051 Aspect Ratio 1024 996

Careers at SonomaBio

We unite our people under a shared commitment to innovation, collaboration, diversity and a sense of belonging, and finding cures for patients.

Learn More